menu
    • menu

    Company profile for Abeona Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. Our expertise across R&D, manufacture, and discovery of novel gene and cell therapies has us uniquely positioned to bring new medicines to patients in need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abeona TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1330 Avenue of the Americas 33rd Floor New York, NY 10019,
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abeonatherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abeonatherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/abeonabio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abeona Therapeutics Grants Inducements Under Nasdaq Rule
    Abeona Therapeutics Grants Inducements Under Nasdaq Rule

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3196908/0/en/Abeona-Therapeutics-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Abeona Therapeutics Reports Q3 2025 Financials & Corporate Update
    Abeona Therapeutics Reports Q3 2025 Financials & Corporate Update

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186123/0/en/Abeona-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Corporate-Updates.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    Abeona Therapeutics Sets Date For Q3 Financial Results
    Abeona Therapeutics Sets Date For Q3 Financial Results

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183564/0/en/Abeona-Therapeutics-Announces-Date-of-Third-Quarter-Financial-Results-and-Upcoming-Investor-Conference-Participation.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Abeona Pharma Secures Permanent J-Code for Zevaskyn
    Abeona Pharma Secures Permanent J-Code for Zevaskyn

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177627/0/en/Abeona-Therapeutics-Announces-Permanent-J-Code-for-ZEVASKYN-prademagene-zamikeracel.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Abeona Pharma Names James A. Gow Senior VP
    Abeona Pharma Names James A. Gow Senior VP

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169368/0/en/Abeona-Therapeutics-Appoints-James-A-Gow-MD-MBA-MS-MHCM-as-Senior-Vice-President-Head-of-Clinical-Development-Medical-Affairs.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    Abeona Pharma's ABO-503 Gene Therapy For XLRS Chosen For FDA
    Abeona Pharma's ABO-503 Gene Therapy For XLRS Chosen For FDA

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165453/0/en/Abeona-Therapeutics-Announces-ABO-503-Gene-Therapy-for-X-linked-Retinoschisis-XLRS-Selected-by-FDA-for-Rare-Disease-Endpoint-Advancement-RDEA-Pilot-Program.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search